Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02263261 · ClinicalTrials.gov registry record · NA

Evaluation of a Human Acellular Dermal Matrix in Post Mastectomy Reconstruction

A NA study, sponsored by Musculoskeletal Transplant Foundation.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT02263261: Completed NA study, sponsored by Musculoskeletal Transplant Foundation.

NCT02263261 is a NA study that has completed, run by Musculoskeletal Transplant Foundation. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02263261, a NA study, has completed, sponsored by Musculoskeletal Transplant Foundation.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

Use of a HADM and implant in post-mastectomy breast reconstruction.

Primary Outcome

Documentaiton of any medical and/or surgical problem requiring treatment that arises as a result of the reconstruction procedure

Interventions

  • OTHER Flex HD Pliable Perforated HADM

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2015-03
Est. Completion 2016-11
Phase NA

What the finished NCT02263261 record still lists

NCT02263261 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Flex HD Pliable Perforated HADM is the first listed.

NCT02263261 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02263261 about?

NCT02263261 is a clinical study titled "Evaluation of a Human Acellular Dermal Matrix in Post Mastectomy Reconstruction". Use of a HADM and implant in post-mastectomy breast reconstruction.

What is the current status of trial NCT02263261?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-03. Estimated completion is 2016-11.

What interventions are being tested in trial NCT02263261?

The interventions under investigation include: Flex HD Pliable Perforated HADM (OTHER).

Who is sponsoring clinical trial NCT02263261?

This trial is sponsored by Musculoskeletal Transplant Foundation, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02263261's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02263261, the US trial registry maintained by the National Library of Medicine. NCT02263261 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.